Binding of mannose-binding lectin to fructosamines: A potential link between hyperglycaemia and complement activation in diabetes

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 4, 2010, Pages 254-260

  Fortpied, Juliette ^a   Vertommen, Didier ^a   Van Schaftingen, Emile ^a  

^a DE DUVE INSTITUTE   (Belgium)

Author keywords

Complement; Diabetes; Fructosamine; Glycation; Lectin

Indexed keywords

COMPLEMENT COMPONENT C3D; FRUCTOSAMINE; LYSINE DERIVATIVE; LYSINOFRUCTOSE; MANNAN; MANNOSE BINDING LECTIN; PROTEINASE; SEPHAROSE; UNCLASSIFIED DRUG;

ARTICLE; CHROMATOGRAPHY; COMPLEMENT ACTIVATION; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPERGLYCEMIA; MASS SPECTROMETRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; WESTERN BLOTTING;

ANIMALS; BLOOD GLUCOSE; CHROMATOGRAPHY, AFFINITY; COMPLEMENT ACTIVATION; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYSINE; MANNOSE-BINDING LECTIN; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

EID: 77952753962     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1079     Document Type: Article

References (31)

1. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-540.
2. Wallis R. Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway. Immunobiology 2007; 212: 289-299.
3. Kilpatrick DC. Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 2002; 1572: 401-413.
4. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37: 1496-1505.
5. Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum Immunol 2006; 67: 247-256.
6. Ezekowitz RA. Genetic heterogeneity of mannose-binding proteins: the Jekyll and Hyde of innate immunity? Am J Hum Genet 1998; 62: 6-9.
7. Gerl VB, Bohl J, Pitz S, Stoffelns B, Pfeiffer N, Bhakdi S. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 2002; 43: 1104-1108. (Pubitemid 34258279)
8. Qin X, Goldfine A, Krumrei N, et al. Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes 2004; 53: 2653-2661.
9. Uesugi N, Sakata N, Nangaku M, et al. Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation. Am J Kidney Dis 2004; 44: 224-238.
10. Vasil KE, Magro CM. Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda. J Am Acad Dermatol 2007; 56: 96-104.
11. Saraheimo M, Forsblom C, Hansen TK, et al. Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 2005; 48: 198-202.
12. Kaunisto MA, Sjölind L, Sallinen R, et al. Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy. Diabetes 2009; 58: 1710-1714.
13. Hovind P, Hansen TK, Tarnow L, et al. Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes 2005; 54: 1523-1527.
14. Hansen TK, Tarnow L, Thiel S, et al. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 2004; 53: 1570-1576.
15. Hansen TK, Gall MA, Tarnow L, et al. Mannose-binding lectin and mortality in type 2 diabetes. Arch Intern Med 2006; 166: 2007-2013
16. Ostergaard J, Thiel S, Gadjeva M, Hansen TK, Rasch R, Flyvbjerg A. Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice. Diabetologia 2007; 50: 1541-1549.
17. Busche MN, Walsh MC, McMullen ME, Guikema BJ, Stahl GL. Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model of diabetes. Diabetologia 2008; 51: 1544-1551.
18. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci U S A 1979; 76: 4258-4261. (Pubitemid 9256541)
19. Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978; 200: 21-27.
20. Delpierre G, Collard F, Fortpied J, Van Schaftingen E. Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes. Biochem J 2002; 365: 801-808.
21. Garlick RL, Mazer JS. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem 1983; 258: 6142-6146. (Pubitemid 13106789)
22. Wiame E, Delpierre G, Collard F, Van Schaftingen E. Identification of a pathway for the utilization of the Amadori product fructoselysine in Escherichia coli. J Biol Chem2002; 277: 42523-42529.
23. Delpierre G, Rider MH, Collard F, et al. Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes 2000; 49: 1627-1634.
24. Szwergold BS, Howell S, Beisswenger PJ. Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo. Diabetes 2001; 50: 2139-2147. (Pubitemid 33643683)
25. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
26. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994; 70: 138-151. (Pubitemid 24090096)
27. Hansen TK, Thiel S, Knudsen ST, et al. Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metab 2003; 88: 4857-4861.
28. Ng KK, Kolatkar AR, Park-Snyder S, et al. Orientation of bound ligands in mannose-binding proteins. Implications for multivalent ligand recognition. J Biol Chem 2002; 277: 16088-16095.
29. Tennent GA, Pepys MB. Glycobiology of the pentraxins. Biochem Soc Trans 1994; 22: 74-79.
30. Okubo Y, Shibata N, Matsumoto T, Suzuki M, Schuerch C, Suzuki S. Immunochemical studies of the mannans of Saccharomyces cerevisiae X2180-1A-5 and Saccharomyces cerevisiae 4484-24D-1 mutant strains, with special reference to their phosphate content. J Bacteriol 1980; 144: 92-96. (Pubitemid 11208810)
31. Baker JR, O'Connor JP, Metcalf PA, Lawson MR, Johnson RN. Clinical usefulness of estimation of serum fructosamine concentration as a screening test for diabetes mellitus. Br Med J (Clin Res Ed) 1983; 287: 863-867.